MedTrace Logo

Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer

NCT00176267 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2023-06-01

No results posted yet for this study

Summary

This study is being performed utilizing two cycles of Paclitaxel and Carboplatin, plus low doses radiation as initial therapy prior to other treatment (surgery or radiation). The study is assessing if utilization of low doses radiation as a chemoenhancer will further increase the response rate seen with initial therapy.

Conditions

Interventions

RADIATION

Radiotherapy

50 cGy on days 1, 2, 8, 15, 22, 23, 29 \& 36 of chemotherapy

DRUG

Paclitaxel

75 mg/m2 intravenously over one hour on Days 1, 8, 15, 22, 29 and 36

DRUG

Carboplatin

AUC of 6 on Days 1 \& 22

Sponsors & Collaborators

Principal Investigators

  • Susanne Arnold, MD · University of Kentucky

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-09-30
Primary Completion
2005-01-31
Completion
2017-01-31

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00176267 on ClinicalTrials.gov